Patents Assigned to FUNDACIÓN KERTOR
  • 1,3,4-oxadiazole derivatives as histone deacetylase inhibitors
    Patent number: 12202823
    Abstract: The present invention refers to oxadiazole compounds suitable as HDAC6 inhibitors. Processes for their preparation and their medical uses in treating HDAC6-related diseases or disorders are also disclosed.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: January 21, 2025
    Assignees: QUIMATRYX, S.L., FUNDACIÓN KERTOR
    Inventors: Yosu Ion Vara Salazar, Eneko Aldaba Arévalo, Tamara Bello Iglesias, Richard Spurring Roberts, Laureano Simón Buela, José Manuel Brea, Ángel Carracedo, María Isabel Loza García